ACR: App Helps Manage Fibromyalgia Through Acceptance and Commitment Therapy

Medically reviewed by Drugs.com.

By Lori Solomon HealthDay Reporter

TUESDAY, Nov. 21, 2023 -- A smartphone-based acceptance and commitment therapy (ACT) app may help patients manage fibromyalgia (FM), according to a study presented at the annual meeting of the American College of Rheumatology, held from Nov. 10 to 15 in San Diego.

Michael Gendreau, M.D., from Gendreau Consulting in Poway, California, and colleagues evaluated the effectiveness of the smartphone-based, prescription digital app FM-ACT. The analysis included 275 individuals meeting 2016 FM diagnostic criteria who were randomly assigned to receive either 12 weeks of FM-ACT or a digital symptom tracker control (ST); all patients remained on any ongoing FM treatment(s).

The researchers found that at week 12, 70.6 percent of the FM-ACT participants reported an improvement on the Patient Global Impression of Change, which was significantly greater than that reported by ST participants (22.2 percent). FM-ACT exposure was significantly associated with a greater posttreatment reduction on the Revised Fibromyalgia Impact Questionnaire total score versus the ST arm (effect size, 0.65). Additionally, FM-ACT was statistically superior to the control treatment for pain intensity and interference, PROMIS Fatigue and Sleep Disturbance, Beck Depression Inventory II, Psychological Inflexibility in Pain Scale, and committed action. There were no treatment-related adverse events reported.

"Validated digital ACT therapy provided by FM-ACT, combined with the low-risk safety profile of this device-based intervention, offers an important step forward in reaching and benefiting the broader FM population with a nondrug therapy," the authors write.

Several authors disclosed financial ties to Swing Therapeutics, the developer of the FM-ACT app.

Press Release

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords